As of November 6, 2026, 3 holders' latest Schedule 13D or 13G filings report owning 5% or more of Phibro Animal Health Corporation. The largest reported stake is BFI Co., LLC's, at 48.2%. 11 filings are on record since December 15, 2025 (Schedule 13D/A, May 22, 2026).
Who owns Phibro Animal Health Corporation?
Sell to companies like Phibro Animal Health Corporation? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Millennium Management LLC · Sole voting: 0 · Shared voting: 822,639 · Sole dispositive: 0 · Shared dispositive: 822,639 · SCHEDULE 13G/A, 2026-10-19
- · Reporting person: Fmr LLC · Sole voting: 3,159,853 · Shared voting: 0 · Sole dispositive: 3,160,281 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-08-06
- · Holder: Millennium Management LLC · Percent: 5.1% · SCHEDULE 13G
- · Holder: BFI Co., LLC · Percent: 48.2% · SCHEDULE 13D/A
- · Holder: Barclays PLC · Percent: 1.27% · SCHEDULE 13G/A
Phibro Animal Health Corporation has 11 Schedule 13D or 13G filings on record since 2025-12-15. 3 holders' latest filing reports 5% or more of class a common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| BFI Co., LLC | 48.2% | 19,552,186 | SCHEDULE 13D/A, 2026-05-22 | 2026-05-20 |
| Fmr LLC | 15% | 3,160,281 | SCHEDULE 13G/A, 2026-08-06 | 2026-06-30 |
| Vanguard Capital Management | 5.06% | 1,043,822 | SCHEDULE 13G, 2026-04-30 | 2026-03-31 |
| Millennium Management LLC | 3.9% | 822,639 | SCHEDULE 13G/A, 2026-10-19 | 2026-09-30 |
| Barclays PLC | 1.27% | 263,695 | SCHEDULE 13G/A, 2026-05-14 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Holding shares or following this stake? See who's behind Phibro Animal Health Corporation and the warning signs.
Free to see. No signup.
Keep reading
More on Phibro Animal Health Corporation and the records around it.
Phibro Animal Health Corporation elsewhere on the record
- Leadership changes Jun 2026
- Who owns it
Companies that share a holder
- Barclays PLC also filed stake reports on 116 other companies: BIGLARI HOLDINGS INC-B (Nov 2026), CABLE ONE INC (Nov 2026), CALISA ACQUISITION CORP (Nov 2026)
- Millennium Management LLC also filed stake reports on 121 other companies: StepStone Group Inc. (Nov 2026), Catalyst Acquisition Corp. (Nov 2026), RxSight, Inc. (Nov 2026)
- FMR LLC also filed stake reports on 761 other companies: ASPEN NEUROSCIENCE INC (Nov 2026), AVALO THERAPEUTICS INC (Nov 2026), BRAZE INC (Nov 2026)
Watch Phibro Animal Health Corporation
Get an email when Phibro Animal Health Corporation files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Phibro Animal Health Corporation?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Phibro Animal Health Corporation: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Phibro Animal Health Corporation covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Fmr LLC | 3,159,853 | 0 | 3,160,281 | 0 | SCHEDULE 13G/A, 2026-08-06 |
| Abigail P. Johnson | 0 | 0 | 3,160,281 | 0 | SCHEDULE 13G/A, 2026-08-06 |
| Millennium Management LLC | 0 | 822,639 | 0 | 822,639 | SCHEDULE 13G/A, 2026-10-19 |
| Millennium Group Management LLC | 0 | 822,639 | 0 | 822,639 | SCHEDULE 13G/A, 2026-10-19 |
| Israel A. Englander | 0 | 822,639 | 0 | 822,639 | SCHEDULE 13G/A, 2026-10-19 |
The latest filing identifies Phibro Animal Health Corporation by CUSIP 71742Q106 and gives its principal executive office as Glenpointe Centre East, 3rd Floor, 300 Frank W. Burr Boulevard, Suite 21, Teaneck, NJ 07666-6712 (SCHEDULE 13G/A, 2026-10-19).
Purpose of Transaction (Item 4)
BFI Co., LLC
Item 4 of the Schedule 13D is hereby supplemented as follows: On May 20 2026, BFI entered into a Rule 10b5-1 sales plan (the "Sales Plan") with Goldman, Sachs & Co. LLC ("Broker") pursuant to which Broker is authorized and directed to sell on behalf of BFI up to 750,000 shares of Class A Common Stock through March 17, 2027, subject to satisfaction of certain conditions, including among others, minimum sale prices and limits on the number of shares that can be sold on a single trading day. All transactions under the Sales Plan are to be made in accordance with the terms and conditions of the Sales Plan. The Sales Plan was adopted to enable BFI to sell a modest portion of its shares of Class A Common Stock (and Class B Common Stock that BFI converts to Class A Common Stock). By using a Rule 10b5-1 Sales Plan, BFI can diversify its investment portfolio over an extended period of time. The Sales Plan became effective as of May 20, 2026 and shall terminate on the earliest of (a) March 17, 2027, (b) the date on which all transactions under the Sales Plan are completed, (c) the date Broker reasonably determines that: (i) the Sales Plan does not comply with Rule 10b5-1(c) or other applicable laws, (ii) BFI has not complied with the Sales Plan, or (iii) BFI's representations or warranties in the Sales Plan are not true and correct, or BFI can no longer make such representations and warranties, (d) the date Broker receives notice of the death, dissolution, liquidation, bankruptcy or …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-05-22; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-12-15 | BFI Co., LLC | 49.3% | SCHEDULE 13D/A |
| 2026-02-11 | Barclays PLC | 5.1% | SCHEDULE 13G |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-07 | Fmr LLC | 10.5% | SCHEDULE 13G |
| 2026-04-23 | BFI Co., LLC | 48.3% | SCHEDULE 13D/A |
| 2026-04-30 | Vanguard Capital Management | 5.06% | SCHEDULE 13G |
| 2026-05-14 | Barclays PLC | 1.27% | SCHEDULE 13G/A |
| 2026-05-22 | BFI Co., LLC | 48.2% | SCHEDULE 13D/A |
| 2026-07-30 | Millennium Management LLC | 5.1% | SCHEDULE 13G |
| 2026-08-06 | Fmr LLC | 15% | SCHEDULE 13G/A |
| 2026-10-19 | Millennium Management LLC | 3.9% | SCHEDULE 13G/A |
Questions about who owns Phibro Animal Health Corporation
Who owns Phibro Animal Health Corporation?
On this page, 3 holders' latest ownership filings report 5% or more of Phibro Animal Health Corporation: BFI Co., LLC (48.2%, Schedule 13D/A, filed 2026-05-22), Fmr LLC (15%, Schedule 13G/A, filed 2026-08-06) and Vanguard Capital Management (5.06%, Schedule 13G, filed 2026-04-30).
Who are the largest shareholders of Phibro Animal Health Corporation?
By the share each holder's latest filing reports, the largest holders of Phibro Animal Health Corporation on this page are BFI Co., LLC (48.2%), Fmr LLC (15%) and Vanguard Capital Management (5.06%).
When did BFI Co., LLC buy into Phibro Animal Health Corporation?
The filings give report dates, not purchase dates. The earliest filing from BFI Co., LLC on this page is the Schedule 13D/A, filed 2025-12-15, reporting 49.3%; its latest, Schedule 13D/A filed 2026-05-22, reports 48.2%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 11 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Phibro Animal Health Corporation
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| June 26, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| April 14, 2026 | Leadership change: Joyce J. Lee departs, Director | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for Phibro Animal Health Corporation. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.